|
|
||||||||
1 Birmingham Heartlands Hospital, Birmingham and 2 Academic Unit of Respiratory Medicine, St Bartholomew's and Royal London School of Medicine, London, UK
CORRESPONDENCE: S. Burge, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK. Fax: 44 1217720292. E-mail: Sherwood.Burge@heartsol.wmids.nhs.uk
Keywords: chronic obstructive pulmonary disease aetiology, definition, exacerbation, incidence, prevention
Received: August 21, 2002
Accepted February 20, 2003
Chronic obstructive pulmonary disease (COPD) is defined independently of exacerbations, which are largely a feature of moderate-to-severe disease. This article is the result of a workshop that tried to define exacerbations of COPD for use in clinical, pharmacological and epidemiological studies. The conclusions represent the consensus of those present.
This review describes definitions, ascertainment, severity assessments, duration and frequency, using varying sources of data including direct patient interview, healthcare databases and symptom diaries kept by patients in studies.
The best general definition of a COPD exacerbation is the following: an exacerbation of COPD is a sustained worsening of the patient's condition, from the stable state and beyond normal day-to-day variations that is acute in onset and may warrant additional treatment in a patient with underlying COPD.
A more specific definition for studies where a bacteriological cause of exacerbation is being studied is included, as well as simpler definitions for retrospective identification from database sources. Prospective diary card assessments are best recorded as changes from an agreed baseline, rather than absolute symptom severities. Diary cards identify many unreported exacerbations, which on average have similar severities to reported exacerbations. A scale for exacerbation severity is proposed that incorporates in- and outpatient assessments. Exacerbation duration, which also relates to severity, is defined from diary card reports. Healthcare utilisation is not an adequate substitute for severity, depending on many unrelated social and comorbidity factors. It is an outcome in its own right.
This article has been cited by other articles:
![]() |
J. L. Wright, M. Cosio, and A. Churg Animal models of chronic obstructive pulmonary disease Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L1 - L15. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Churg, M. Cosio, and J. L. Wright Mechanisms of cigarette smoke-induced COPD: insights from animal models Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L612 - L631. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. W. Diederen, P. D. L. P. M. van der Valk, J. A. W. J. Kluytmans, M. F. Peeters, and R. Hendrix The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease Eur. Respir. J., August 1, 2007; 30(2): 240 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Scott, P Walker, and P M A Calverley COPD exacerbations {middle dot} 4: Prevention Thorax, May 1, 2006; 61(5): 440 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fujimoto, M. Yasuo, K. Urushibata, M. Hanaoka, T. Koizumi, and K. Kubo Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Eur. Respir. J., April 1, 2005; 25(4): 640 - 646. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |